Popular on Amzeal
- Best Real Estate Brokerage to Work for
- QView Medical and GEHC Sign a Distribution Agreement
- SIGLENT Technologies Releases 8-Channel Low Profile Oscilloscope, the SDS6000L series
- THE PROJECTION BOOTH Podcast Celebrates 12 Years With Continued Quality and Amazing Guests!
- Emerging Technology Group Expands Offerings with New Partnerships and Technology Solutions
- Quala Selects PhaseZero to Modernize its Digital Customer Experience
- Blockchain Institute of Technology Announces New Crowdfunding Campaign to Scale Global Operations and Expand Reach
- Free Guided Grief Journal Program Launches on MLK Day of Service
- World's First & Only Prenatal Vitamin Designed FOR Vegans by Future Kind
- West Bend Area Real Estate Agent Promotes Homes To MORE Buyers For MORE Money
Similar on Amzeal
- Texas Automotive Lift & Equipment Distributor chooses Employees Ownership
- Paramount Completes Acquisition of First National ATM
- Fintech Startup BeFiSc Launches AI/ML Powered KYC Solutions Beyond Financial Scores
- Yida Gao and Shima Capital Celebrate Portfolio Company's Successful NFT Sellout
- The Case For Bonds As Part Of A Portfolio
- Cardinal Analytics Launches on the Bloomberg App Portal
- Orbex to Exhibit as Diamond Sponsor at the Fintech & Crypto Summit Bahrain, 2023
- Yida Gao, Shima Capital Recognized for Prolific Deal Activity
- STS Capital Partners Announces Sean Friday as New Chief Executive Officer
- ATM Processing Provider DNS Certifies Just.Cash Bitcoin Program
Ysios Capital strengthens its team with internal promotions and a new Venture Partner
Amzeal News/10511024
Jordi Xiol has been promoted to Partner after joining Ysios Capital in 2019 and Salvatore Scaffidi, who joined the Ysios Fellowship program in 2020, has been promoted to Associate.
Ysios is also incorporating Sanifit co-founder and CEO Joan Perelló as Venture Partner.
These appointments add operational capacities supporting Ysios' mission to build leading life sciences companies.
Ysios is also incorporating Sanifit co-founder and CEO Joan Perelló as Venture Partner.
These appointments add operational capacities supporting Ysios' mission to build leading life sciences companies.
BARCELONA, Spain - Amzeal -- Ysios Capital, a European life sciences venture capital firm, today announced the promotions of Jordi Xiol to Partner and Salvatore Scaffidi to Associate, as well as the appointment of Joan Perelló as Venture Partner.
Jordi Xiol joined Ysios Capital in 2019 as an Associate and his contribution to the identification and evaluation of investment opportunities has been outstanding. Prior to joining Ysios, Jordi worked at Vida Ventures in Boston, where he focused on opportunities in oncology, gene therapy, and ophthalmology. In his new role he will be responsible for making and managing investments. He is currently a member of the board of directors of Northsea Therapeutics and Splice Bio, and an observer on the board of directors of Adcendo and Cytoki.
More on Amzeal News
Salvatore Scaffidi joined Ysios Capital in 2021 as an Analyst after successfully completing Ysios' Fellowship program. Prior to joining Ysios, Salvatore received a PhD from the University of Barcelona (UB), where he studied protein-ligand complexes using biophysical techniques. As an Associate, he will source and evaluate investment opportunities. Salvatore is currently a board observer at Splice Bio.
"The human capital is our key and only asset. These promotions reflect our commitment to foster and value top talent." commented Joël Jean-Mairet, Managing Partner at Ysios Capital.
Joan Perelló, a highly accomplished serial life sciences entrepreneur, has been appointed as a new Venture Partner at Ysios Capital. With 15+ years of management experience in various organizations, including as CEO, Non-Executive Director, President and Chairman, Joan Perelló is a respected figure in the life sciences industry. He is co-founder and CEO of Sanifit, a biotech company that raised over €140M in equity and debt financing before it was acquired by Vifor for €375M + sales milestones, the biggest exit of the Spanish Biotech sector. Joan is Chairman of the Board at CIRCE Crystal Engineering, President of the Balearic Cluster of Biotechnology and Biomedicine and Vice-Dean at the Official College of Chemists in the Balearic Islands, Spain.
More on Amzeal News
Joan Perelló holds an MSc in Chemistry with first-class honors and earned his PhD from the University of the Balearic Islands, Spain, where he teaches Analytical and Clinical Chemistry as an Associate Professor.
"I have known the Ysios team for over a decade and have long admired their work in building Europe's, and in particular Spain's, leading life sciences companies. With their strong brand, international network, and excellent scientific backgrounds, they transform capital into medical breakthroughs." commented Joan Perelló, Venture Partner at Ysios Capital.
Julia Salaverria, Managing Partner at Ysios also added: "Joan is a highly accomplished serial entrepreneur and has created one of the key success stories in Spain. We are honored to be working with him as we continue to build leading life sciences companies."
Joan Perelló will join Ysios Capital Venture Partners' base of internationally renowned experts currently formed by Toni Ribas, world expert in immuno-oncology, former President of the American Association for Cancer Research (AACR) and Professor at the University of California Los Angeles (UCLA); Pamela Klein, former VP Development at Genentech/Roche; Carlos Payá, expert in Immunology and infectious diseases, previously in various leadership roles at Eli Lilly in and CEO of Immune Design until its acquisition by Merck & Co., David Lacey, former Senior VP and Global Head of Discovery Research at Amgen, and Lance Berman who has more than 20 years of clinical development experience in big pharma and the biotech start-ups.
Jordi Xiol joined Ysios Capital in 2019 as an Associate and his contribution to the identification and evaluation of investment opportunities has been outstanding. Prior to joining Ysios, Jordi worked at Vida Ventures in Boston, where he focused on opportunities in oncology, gene therapy, and ophthalmology. In his new role he will be responsible for making and managing investments. He is currently a member of the board of directors of Northsea Therapeutics and Splice Bio, and an observer on the board of directors of Adcendo and Cytoki.
More on Amzeal News
- The Data Economics Company and Gordian Knot Strategies Announce Enkrateia Climate Investment Decision Support Platform
- Anniversary of Planet Pluto Discovery Day Celebrated by Author's Space Books for Kids
- Americana Songstress Emma Jo To Release Powerful New Single, 'Straight Into Mine'
- IISE announces leadership election results
- JD Merit & Co. Advises Amtech Systems, Inc. in its Acquisition of Entrepix, Inc
Salvatore Scaffidi joined Ysios Capital in 2021 as an Analyst after successfully completing Ysios' Fellowship program. Prior to joining Ysios, Salvatore received a PhD from the University of Barcelona (UB), where he studied protein-ligand complexes using biophysical techniques. As an Associate, he will source and evaluate investment opportunities. Salvatore is currently a board observer at Splice Bio.
"The human capital is our key and only asset. These promotions reflect our commitment to foster and value top talent." commented Joël Jean-Mairet, Managing Partner at Ysios Capital.
Joan Perelló, a highly accomplished serial life sciences entrepreneur, has been appointed as a new Venture Partner at Ysios Capital. With 15+ years of management experience in various organizations, including as CEO, Non-Executive Director, President and Chairman, Joan Perelló is a respected figure in the life sciences industry. He is co-founder and CEO of Sanifit, a biotech company that raised over €140M in equity and debt financing before it was acquired by Vifor for €375M + sales milestones, the biggest exit of the Spanish Biotech sector. Joan is Chairman of the Board at CIRCE Crystal Engineering, President of the Balearic Cluster of Biotechnology and Biomedicine and Vice-Dean at the Official College of Chemists in the Balearic Islands, Spain.
More on Amzeal News
- KITROBOT Intelligent System Corp. Introduces an AI-Powered Disinfecting Robot For Automated Cleaning
- People First Content Cracks the Code on AI Writing Software
- Hookahville 56 Lineup Announcement
- Daugherty Business Solutions Named a Top Workplace by Energage
- Climate Institute Signs Agreement with Swiss-Based 2000-Watt Smart Cities Association to Promote New Climate Change Programs in the United States
Joan Perelló holds an MSc in Chemistry with first-class honors and earned his PhD from the University of the Balearic Islands, Spain, where he teaches Analytical and Clinical Chemistry as an Associate Professor.
"I have known the Ysios team for over a decade and have long admired their work in building Europe's, and in particular Spain's, leading life sciences companies. With their strong brand, international network, and excellent scientific backgrounds, they transform capital into medical breakthroughs." commented Joan Perelló, Venture Partner at Ysios Capital.
Julia Salaverria, Managing Partner at Ysios also added: "Joan is a highly accomplished serial entrepreneur and has created one of the key success stories in Spain. We are honored to be working with him as we continue to build leading life sciences companies."
Joan Perelló will join Ysios Capital Venture Partners' base of internationally renowned experts currently formed by Toni Ribas, world expert in immuno-oncology, former President of the American Association for Cancer Research (AACR) and Professor at the University of California Los Angeles (UCLA); Pamela Klein, former VP Development at Genentech/Roche; Carlos Payá, expert in Immunology and infectious diseases, previously in various leadership roles at Eli Lilly in and CEO of Immune Design until its acquisition by Merck & Co., David Lacey, former Senior VP and Global Head of Discovery Research at Amgen, and Lance Berman who has more than 20 years of clinical development experience in big pharma and the biotech start-ups.
Source: Ysios Capital Partners
Filed Under: Financial
0 Comments
Latest on Amzeal News
- Zilker Partners Expands Recruiting and Digital Marketing Services to Keep Pace with Changing Business Climate
- Dental Tourism is on the Rise and This Dental Hygienist is Providing the Consultations
- New Book Launches to Bestseller Status--Answers the Question "Why Is It So Hard to Find Quality Workers?"
- Cascade Asset Management Recognized in 2023 Gartner® Market Guide for IT Asset Disposition Report
- Retired OC Police Officer Launches Caregiver Consulting Company
- Technology to protect technology — TenCate Advanced Armor USA offers armored optronics casings in the United States
- The Anderson Periodontal Wellness Office Now Uses Zirconia Dental Implants to Restore Smiles!
- Beyond X Chibi Labs Unveil Gravitale
- Goosechase launches new Interactive Experiences community, The Nest
- Paramount Completes Acquisition of First National ATM
- ASI Welcomes New Chief Revenue Officer and Chief Operating Officer
- Unitirreno Announces Contract-in-Force For New Subsea Cable System in the Tyrrhenian Sea
- UMe Celebrates Songwriter PAUL JABARA's Birthday With Newly Remastered Version of Casablanca 's Paul Jabara's Greatest Hits…and Misses
- Fintech Startup BeFiSc Launches AI/ML Powered KYC Solutions Beyond Financial Scores
- Bob Holz New Video with Darryl Jones of the Rolling Stones, Concert, Album and Endorsement
- VSA Prospecting Launches New Website, Enhancing the User Experience
- Yida Gao and Shima Capital Celebrate Portfolio Company's Successful NFT Sellout
- "Murdaugh Murders Podcast" Launches Spinoff "Cup of Justice" and Skyrockets to Apple's #1 Podcast
- CPAC 2023 Congressional Candidate Forum Meet and Greet March 2nd at the historic University Club in DC
- IoT Observatory to host Plenary Session at 2023 InsurTech Hartford Symposium